Beate
Beate Bannemann, Vallendar DE
Patent application number | Description | Published |
---|---|---|
20150072167 | TINPLATE, COATED WITH A POLYMER COATING, AND METHODS FOR ITS PRODUCTION - A method for the coating of a chromium-free surface of a tin-plated steel sheet with a polymer coating, with the chromium-free tin surface of the tin-plated steel sheet first electrochemically oxidized in a first step and a polymer coating applied on the oxidized tin surface in a second step, and an apparatus for the carrying out of the method. A tinplate coated with a polymer coating made of polyethylene terephathalate (PET) and passivated chromium-free, wherein only one thin tin oxide layer and perhaps an adhesion promoter layer are present between the tin surface of the tinplate and the polymer coating, and the use of such a tinplate for the production of packagings. | 03-12-2015 |
Beate Bleeker, München DE
Patent application number | Description | Published |
---|---|---|
20090155653 | FUEL CELL SYSTEM - The invention relates to a fuel cell system comprising a reformer and an afterburner each for reacting at least fuel and an oxidant; and a fuel feeder for supplying the reformer and the afterburner with fuel. It is provided for to particular advantage that at least one flow control valve for controlling the fuel supply is included upstream of at least the reformer or the afterburner. The invention relates furthermore to a motor vehicle having one such fuel cell system. | 06-18-2009 |
Beate Bleeker, Munich DE
Patent application number | Description | Published |
---|---|---|
20090246571 | DETERMINATION OF THE LAMBDA VALUE OF REFORMATE WITH THE AID OF A FUEL CELL - The invention relates to a process for determining the lambda value (λ | 10-01-2009 |
20090297898 | REFORMING SYSTEM, METHOD FOR OPERATING A REFORMING SYSTEM AND FUEL CELL SYSTEM - The invention relates to a reformer system for generating a hydrogen-rich reformate comprising a reformer to which fuel and an oxidising agent can be supplied. According to the invention it is contemplated that the fuel supplied to the reformer is at least partly coolable by a fluid having other functions in addition to the function of cooling the fuel in the reformer system or a parent system into which the reformer system is integrated. The invention further relates to a method for generating a hydrogen-rich reformate as well as a fuel cell system comprising a reformer system according to the invention. | 12-03-2009 |
20100212977 | REFORMER FOR A FUEL CELL SYSTEM AND METHOD FOR OPERATING SAID REFORMER - The invention relates to a reformer ( | 08-26-2010 |
20100212991 | FUEL CELL SYSTEM COMPRISING A REFORMER AND AN AFTERBURNER - The invention relates to a fuel cell system ( | 08-26-2010 |
20110117464 | FUEL CELL SYSTEM AND METHOD FOR INFLUENCING THE THERMAL BALANCE OF A FUEL CELL SYSTEM - The invention relates to a fuel cells system ( | 05-19-2011 |
Beate Bleeker, München DE
Patent application number | Description | Published |
---|---|---|
20090155653 | FUEL CELL SYSTEM - The invention relates to a fuel cell system comprising a reformer and an afterburner each for reacting at least fuel and an oxidant; and a fuel feeder for supplying the reformer and the afterburner with fuel. It is provided for to particular advantage that at least one flow control valve for controlling the fuel supply is included upstream of at least the reformer or the afterburner. The invention relates furthermore to a motor vehicle having one such fuel cell system. | 06-18-2009 |
Beate Buerglen, Jena DE
Patent application number | Description | Published |
---|---|---|
20090117183 | ORAL CONTRACEPTIVE CONTAINING A GESTAGEN AND AN ESTROGEN COMBINED WITH PHARMACEUTICALLY ACCEPTABLE AUXILIARY AGENTS AND/OR EXCIPIENTS, BUT NOT CONTAINING LACTOSE, AND METHOD OF MAKING SAME - The method produces a lactose-free oral contraceptive composition containing a combination of a gestagen and an estrogen together with one or more pharmaceutically acceptable auxiliary agents and/or excipients. The contraceptive composition is a tablet, powder, or capsule that contains the gestagen and estrogen, filler material such as microcrystalline cellulose and a binder such as hydroxypropylcellulose, but no lactose. Preferably the gestagen is dienogest, chlormadinone acetate, or levonorgestrel and the estrogen is ethinylestradiol, 17β-estradiol, or estradiol valerate. A method is provided for improving the prophylaxis of lactose intolerance in women taking oral contraceptives. The oral contraceptive preparations for a standard 28-day cycle or for long-term use contain at least 21 daily dose units of the gestagen and the estrogen in a low-dosage but without lactose and at most 7 daily dose units containing no active ingredient or a placebo. | 05-07-2009 |
20090117184 | Use of a gestagen in combination with an estrogen and one or more pharmaceutically acceptable auxiliary agents/excipients for lactose-free oral contraception - Gestagens, preferably dienogest, chlormadinone acetate or levonorgestrel, in combination with estrogens, for example ethinylestradiol, 17β-estradiol or estradiol valerate, and one or more pharmaceutically acceptable auxiliary agents/excipients provide lactose-free oral contraception. | 05-07-2009 |
Beate Celmerowski, Gunningen DE
Patent application number | Description | Published |
---|---|---|
20130035725 | CONNECTING ELEMENT FOR A STABILIZATION SYSTEM FOR THE VERTEBRAL COLUMN, AND STABILIZATION SYSTEM FOR THE VERTEBRAL COLUMN - To improve a connecting element for a stabilization system for the vertebral column, which includes a first attachment section for fixing to a first bone fixation device, a second attachment section for fixing to a second bone fixation device, and an at least partially flexible intermediate section having at least one recess which is open at the sides, that at least one mechanical property of the intermediate section can be individually set in a simple and safe way, at least one movement limiting member is provided, which comprises a filling body and at least one stop device acting parallel or substantially parallel to the longitudinal axis and/or in the circumferential direction, and that the filling body, in a normal position in which no external forces act on the intermediate section, engage at least partially in the at least one recess. | 02-07-2013 |
20150080955 | CONNECTION ELEMENT AND SPINE STABILIZATION SYSTEM - The present invention relates to a connection element for a spine stabilization system comprises a first end for fixing to a first bone fixation device, a second end for fixing to a second bone fixation device and an intermediate portion arranged or formed between the two ends and defining a longitudinal axis. At least one of the two ends takes the form of a coupling element for fixing the connection element to a bone fixation device in at least one defined orientation relative to the longitudinal axis. The coupling element has a shape other than a circular cylinder. | 03-19-2015 |
Beate Celmerowski, Spaichingen DE
Patent application number | Description | Published |
---|---|---|
20080230423 | Holding device for an implant - In order to improve a holding device for an implant, comprising a first connecting device for releasably connecting the holding device and the implant, such that very small implants, in particular, are easy to handle, it is suggested that the holding device have a second connecting device for releasably connecting the holding device and a storage unit. | 09-25-2008 |
Beate Diefenbach-Streiber, Windach DE
Patent application number | Description | Published |
---|---|---|
20090130113 | Compositions and methods for use for antibodies against sclerostin - The present invention relates to antibodies against sclerostin and compositions and methods of use for said antibodies to treat disease related to bone abnormalities such as osteoporosis. An embodiment of the invention herein provides an antibody or a functional protein comprising an antigen-binding portion of said antibody for a target in sclerostin polypeptide, characterized in that the antibody or functional protein specifically binds to sclerostin polypeptide and can increase at least one of bone formation, bone mineral density, bone mineral content, bone mass, bone quality and bone strength in a mammal. | 05-21-2009 |
20100034809 | Compositions and Methods for Antibodies Targeting Complement Protein C5 - The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof. | 02-11-2010 |
20110052592 | Compositions and Methods for Use for Antibodies Against Sclerostin - The present invention relates to antibodies against sclerostin and compositions and methods of use for said antibodies to treat a pathological disorder that is mediated by sclerostin or disease related to bone abnormalities such as osteoporosis. | 03-03-2011 |
20120276591 | Compositions and Methods for Use for Antibodies Against Sclerostin - The present invention relates to antibodies against sclerostin and compositions and methods of use for said antibodies to treat a pathological disorder that is mediated by sclerostin or disease related to bone abnormalities such as osteoporosis. | 11-01-2012 |
20130022615 | Compositions and Methods for Antibodies Targeting Complement Protein C5 - The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof. | 01-24-2013 |
20130064836 | Compositions and Methods for Antibodies Targeting Complement Protein C5 - The present invention relates to antibodies targeting complement protein C5 and compositions and methods of use thereof. | 03-14-2013 |
20140112915 | IL-18 binding molecules - IL-18 participates in both innate and acquired immunity. The bioactivity of IL-18 is negatively regulated by the IL-18 binding protein (IL18BP), a naturally occurring and highly specific inhibitor. This soluble protein forms a complex with free IL-18 preventing its interaction with the IL-18 receptor, thus neutralizing and inhibiting its biological activity. The present invention discloses binding molecules, in particular antibodies or fragments thereof, which bind IL-18 and do not bind IL-18 bound to IL-18BP (IL-18/IL-18BP complex). Apart from its physiological role, IL-18 has been shown to mediate a variety of autoimmune and inflammatory diseases. The binding molecules of the inventions may be used as therapeutic molecules for treating IL-18-related autoimmune and inflammatory diseases or as diagnostic tools for characterizing, detecting and/or measuring IL-18 not bound to IL-18BP as component of the total IL-18 pool. | 04-24-2014 |
Beate Frohling, Neustadt DE
Patent application number | Description | Published |
---|---|---|
20130139328 | DISULFIDE OR THIOL POLYMERIC HAIR DYES - The present invention relates to the reaction product of (A) a polymeric backbone with (B) A chromophore; and with (C) at least one sulfide containing compound. Very good dyeing results are obtained with this new technology. | 06-06-2013 |
20140157529 | DISULFIDE DYES - Disclosed are compounds of formula (1) or formula (2). The compounds are useful for the dyeing of organic materials, such as keratin fibers, wool, leather, silk, cellulose or polyamides, especially keratin-containing fibers, cotton or nylon, and preferably hair, more preferably human hair. (1) (2). | 06-12-2014 |
Beate Frohling, Steinen DE
Patent application number | Description | Published |
---|---|---|
20080295260 | Disulfide Dyes, Composition Comprising them and Method of Dyeing Hair - Formula (I) wherein R | 12-04-2008 |
Beate Fröhling, Neustadt DE
Patent application number | Description | Published |
---|---|---|
20120012128 | HAIR DYEING COMPOSITION - Disclosed is a hair dyeing composition comprising (a) a dye of formula (1); (b) at least one dye selected from the compounds of formulae (2); wherein D is the radical of a diazo component of the formula (2a); K is the radical of a coupling component selected from aniline derivatives; phenol derivatives; and a radical of a heterocyclic coupling component; X is O—; —S—; or N(R | 01-19-2012 |
20120017931 | HAIR DYEING COMPOSITION - Hair dyeing composition comprising (a) a dye of formula (1) (b) at least one dye selected from the compounds of formulae (2) (3) (4) wherein D is the radical of a diazo component of the formula (2 | 01-26-2012 |
20120110750 | POLYMERIC HAIR DYES - Disclosed are polymeric dyes of formula (1a), (1b), or (1c); wherein A and B, independently from each other represent a polymer backbone; X | 05-10-2012 |
Beate Fröhling, Grenzach-Wyhlen DE
Patent application number | Description | Published |
---|---|---|
20090217465 | Process for Hair Dyeing Comprising Application of Composite Pigment - Disclosed is a process for dyeing of keratin-containing fibers comprising treating the fibers with at least one functionalized particle comprising on the surface an organic chromophore which is bound via a bridge member, wherein the particles are based on SiO | 09-03-2009 |
20090255063 | Polymeric hair dyes - Disclosed are polymeric dyes of formula (1a); (1b); or (1c); wherein A and B, independently from each other represent a polymer backbone; X | 10-15-2009 |
20090293208 | Cationic oligomeric azo dyes - Disclosed are oligomeric cationic azo dyes of formula (I), wherein their salts, isomers, hydrates and other solvates, wherein R | 12-03-2009 |
20090300855 | Pyrido Thiazinium Dyes - Disclosed is a method of dyeing keratin-containing fibers comprising treating the fiber with at least one compound of formula (1), wherein R | 12-10-2009 |
20090300857 | DYES CONTAINING A THIOL GROUP - Disclosed are thiol dyes of formula (1), wherein R | 12-10-2009 |
20100000028 | Styryl sulfide dyes - Disclosed are styryl sulfide dyes of formula (1), wherein R | 01-07-2010 |
20100000029 | THIOL DERIVATIVE DYES - Disclosed are thiol dyes of formula (1) wherein L1 is hydrogen; C | 01-07-2010 |
Beate Gnass, Gersthofen DE
Patent application number | Description | Published |
---|---|---|
20150080501 | Combination of a Stable Nitroxyl Radical and a Quinone Methide as Stabiliser for Reaction Resin Mortars Based on Radically Curable Compounds - The use of a combination of at least one stable nitroxyl radical and at least one quinone methide as a stabilizer for resin mixtures and reactive resin mortars, each based on radically curable compounds, is described. Resin mixtures and in particular reactive resin mortars may be combined very effectively with a combination of at least one stable nitroxyl radical and at least one quinone methide to make them stable in storage. | 03-19-2015 |
Beate Grzondziel, Gebenstorf CH
Patent application number | Description | Published |
---|---|---|
20090126190 | METHOD FOR PRODUCING A TURBINE CASING - A method for producing a turbine casing for a rotating machine is provided. The casing is manufactured by a casting process, and is cast in two casing halves which are separated by a parting plane which passes axially through the turbine casing. Each casing half is first cast in one piece in each case, and each casing half is separated into at least two casing sections which are joined together for forming a casing half in each case. | 05-21-2009 |
20130336783 | DIFFUSER FOR TURBOMACHINES - A diffuser is described with an entry section close to the last stage of a turbine having an outer wall including several subsequent straight wall parts at an angle to each other followed by a curved wall part with the curved wall part connecting the straight wall parts to a diffuser lip or exit and having as vertical cross-section a non-circular 2 | 12-19-2013 |
Beate Hertäg, Leinzell DE
Patent application number | Description | Published |
---|---|---|
20150224960 | BELT RETRACTOR FOR A SEAT-BELT - A belt retractor ( | 08-13-2015 |
Beate Ibounig, Wien AT
Beate Illek, Albany, CA US
Patent application number | Description | Published |
---|---|---|
20100286256 | COMPOSITIONS AND METHODS FOR THERAPY FOR DISEASES CHARACTERIZED BY DEFECTIVE CHLORIDE TRANSPORT - Compositions and methods for therapy of cystic fibrosis, asthma, and other conditions characterized by defective chloride transport are provided. The compositions comprise one or more compounds such as flavones and/or isoflavones, ascorbate and/or derivatives thereof capable of stimulating chloride transport in epithelial tissues. Therapeutic methods involve the administration (e.g., orally or via inhalation) of such compositions to a patient afflicted with cystic fibrosis, asthma, and/or another condition responsive to stimulation of chloride transport. | 11-11-2010 |
Beate Kälz, Steinbrunn AT
Patent application number | Description | Published |
---|---|---|
20090253743 | COMPOSITIONS OF TOLPERISONE - The present disclosure is directed to methods for providing tolperisone having extremely low levels of 4-MMPPO (2-methyl-1-(4-methylphenyl)-propenone), as well as related compositions. The invention further relates to methods of treating a subject with tolperisone under conditions that limit exposure of the subject to tolerable levels of 4-MMPPO, among other features. | 10-08-2009 |
20090326219 | PROCESS FOR MANUFACTURING EXTREMELY PURE BENZAZEPINE DERIVATIVES - A process for the production of extremely pure galanthamine or extremely pure galanthamine derivatives, a start is made from racemic bromine narwedine, which is debrominated under palladium catalysis. In this case, the working-up of the reaction mixture, which is carried out in the presence of oxygen or peroxides so that the palladium catalyst in an insoluble form is converted into an easily separable form, is essential. The further reaction is carried out by reduction of enantiomer-pure narwedine to form enantiomer-pure galanthamine, whereby it is then alkylated or dealkylated so that a corresponding substitution on the ring-nitrogen atom is achieved. By further purification, such as recrystallization, residual portions of palladium of below 5 ppm are achieved, so that direct use as a pharmaceutical raw material is made possible. | 12-31-2009 |
20100150995 | PROCESS FOR THE PRODUCTION OF HIGH-PURITY 2,4'-DIMETHYL-3-PIPERIDINO-PROPIOPHENONE (TOLPERISONE), PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THE LATTER, AS WELL AS ACTIVE INGREDIENT FORMULATIONS THAT CONTAIN TOLPERISONE - The invention relates to a method for producing highly pure 2,4′-dimethyl-3-piperidino-propiophenone (tolperisone) (formula I) and the pharmaceutically acceptable salts, hydrochlorides, and hydrates thereof. The method allows the content of the undesired byproduct 2-methyl-1-(4-methylphenyl) propenone (4-MMPPO) to be kept significantly lower than in previously known methods. The invention further relates to active substance formulations which contain tolperisone and are suitable, among other things, for producing combination preparations used for treating patients suffering from Alzheimer's disease. The invention also relates to topical formulations, controlled release (CR) formulations, and transdermal therapeutic systems, such as active substance patches, which contain less than 50 ppm, preferably less than 10 ppm, more preferably less than 7 ppm, and most preferably less than 3 ppm or 0 ppm (i.e. less than the detectable amount) of the undesired byproduct 2-methyl-1-(4-methylphenyl) propenone (4-MMPPO) in relation to 100 percent by weight of active substance. | 06-17-2010 |
20100249423 | TOLPERISONE CONTROLLED RELEASE TABLET - A GRDDS (Gastro Retentive Drug Delivery System) containing tolperisone and having a 2-methyl-1-(4-methylphenyl)-propenone (4-MMPPO) fraction of less than 1.5 ppm for the extended release of the active substance tolperisone while avoiding the formation of 4-MMPPO in the gastrointestinal tract. | 09-30-2010 |
Beate Kälz, Steinbrunn AT
Patent application number | Description | Published |
---|---|---|
20090326219 | PROCESS FOR MANUFACTURING EXTREMELY PURE BENZAZEPINE DERIVATIVES - A process for the production of extremely pure galanthamine or extremely pure galanthamine derivatives, a start is made from racemic bromine narwedine, which is debrominated under palladium catalysis. In this case, the working-up of the reaction mixture, which is carried out in the presence of oxygen or peroxides so that the palladium catalyst in an insoluble form is converted into an easily separable form, is essential. The further reaction is carried out by reduction of enantiomer-pure narwedine to form enantiomer-pure galanthamine, whereby it is then alkylated or dealkylated so that a corresponding substitution on the ring-nitrogen atom is achieved. By further purification, such as recrystallization, residual portions of palladium of below 5 ppm are achieved, so that direct use as a pharmaceutical raw material is made possible. | 12-31-2009 |
20100249423 | TOLPERISONE CONTROLLED RELEASE TABLET - A GRDDS (Gastro Retentive Drug Delivery System) containing tolperisone and having a 2-methyl-1-(4-methylphenyl)-propenone (4-MMPPO) fraction of less than 1.5 ppm for the extended release of the active substance tolperisone while avoiding the formation of 4-MMPPO in the gastrointestinal tract. | 09-30-2010 |
Beate Kamlage, Berlin DE
Patent application number | Description | Published |
---|---|---|
20080234945 | Means and Methods for Analyzing a Sample by Means of Chromatography-Mass Spectrometry - The present invention relates to a method for analyzing at least one test sample, wherein said test sample comprises at least one compound, said method comprising the steps of: a) providing at least one test sample comprising at least one compound; b) determining said at least one compound in said test sample whereby raw results are generated; and c) analyzing the raw results obtained in step b), wherein the analysis of said at least one test sample is accompanied by an analysis of at least one reference sample; and wherein the test sample and the reference sample are analyzed in an identical sequence in each step of the method. Moreover, the present invention further encompasses a system for carrying out said method comprising operatively linked to each other: (a) means for determining a compound; (b) means for monitoring process parameters, (c) means for analyzing raw results obtained from the means according to (a), wherein said means for analyzing raw results comprise: (i) a first database comprising raw results received from the means according to (a); (ii) a second database comprising monitored process parameters received from the means according to (b); (iii) a third database comprising rules for evaluating the raw results; and (iv) a fourth database comprising allocated results of identified compounds; wherein at least the second, third and fourth database are operatively linked to the first database. | 09-25-2008 |
20090300794 | Manipulation Of The Nitrogen Metabolism - The present invention relates to the manipulation of the nitrogen metabolism in photosynthetic active organisms, preferably in plants. In particular, the present invention relates to a process for the enhanced nitrogen assimilation, accumulation and/or utilization and/or for the increased total nitrogen content in a photosynthetic active organism. | 12-03-2009 |
20100031380 | IDENTIFICATION OF CHILLING-RESISTANT PLANTS - A process for identifying whether plant is resistant to chilling comprises cultivating the plant at a reduced temperature for a time period selected from short term and medium term; harvesting a tissue sample of the plant; measuring concentration of at least one metabolite in the tissue sample of the plant; comparing the measured concentration with the concentration of the same metabolite in a tissue sample harvested from a reference plant or a plant of the same species after cultivation at a reference temperature; and optionally, repeating the process of foregoing steps but cultivating the plant at a reduced temperature for a time period selected from short term and medium term and not previously used; wherein resistance to chilling is indicated by one or more of the effects on metabolites listed in Table 2 or Table 4. | 02-04-2010 |
20110035841 | Lipid Metabolism Proteins, Combinations of Lipid Metabolism Proteins and Uses Thereof - Described herein are inventions in the field of genetic engineering of plants, including combinations of polynucleotides encoding LMPs to improve agronomic, horticultural, and quality traits. This invention also relates to the combination of polynucleotides encoding proteins that are related to the presence of seed storage compounds in plants. More specifically, the present invention relates to LMP polynucleotides encoding lipid metabolism proteins (LMP) and the use of these combinations of these sequences, their order and direction in the combination, and the regulatory elements used to control expression and transcript termination in these combinations in transgenic plants. In particular, the invention is directed to methods for manipulating fatty acid-related compounds and for increasing oil and starch levels and altering the fatty acid composition in plants and seeds. The invention further relates to methods of using these novel combinations of polypeptides to stimulate plant growth, and/or root growth and/or to increase yield and/or composition of seed storage compounds. | 02-10-2011 |
20110113863 | MEANS AND METHODS DIAGNOSING GASTRIC BYPASS AND CONDITIONS RELATED THERETO - The present invention relates to the field of diagnostic measures. Specifically, it contemplates a method for assessing whether gastric bypass therapy was successful in a subject, a method of predicting whether gastric bypass therapy will be beneficial for a subject in need thereof, and a method of diagnosing whether a supportive therapy accompanying gastric bypass has beneficial effects on a subject in need thereof. Further provided are diagnostic methods for diabetes and body lean mass. Furthermore, the invention relates to a method for identifying a treatment against diabetes and/or obesity. | 05-19-2011 |
20110252509 | Method for Producing a Transgenic Cell with Increased Gamma-Aminobutyric Acid (Gaba) Content - This invention relates generally to a method for producing a transgenic cell with increased gamma-aminobutyric acid (GABA) content as compared to a corresponding non-transformed wild type cell. | 10-13-2011 |
20120005777 | Process for the Production of Fine Chemicals - The present invention relates to a process for the production of fine chemicals in a microorganism, a plant cell, a plant, a plant tissue or parts thereof. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antisense molecules, antibodies, host cells, plant tissue, propagtion material, harvested material, plants, microorganisms as well as agricultural compositions and to their use. | 01-05-2012 |
20120122243 | MEANS AND METHOD AND MEANS FOR DIAGNOSING PROSTATE CARCINOMAS - The present invention relates to a method, preferably an ex vivo method, for diagnosing prostate carcinomas and/or predisposition thereof comprising determining at least one metabolite in a test sample of a subject suspected to suffer from prostate carcinomas or to have a predisposition therefor and comparing said at least one metabolite to a reference, whereby prostate carcinomas or a predisposition therefor is to be diagnosed. Moreover, the present invention encompasses a collection of metabolites, a data collection comprising characteristic values of metabolites and a storage medium comprising said data collection. Furthermore, the present invention also relates to a system comprising means for comparing characteristic values of metabolites of a sample operatively linked to a data storage medium. Further encompassed by the present invention are diagnostic means comprising at least one metabolite and the use of said at least one metabolite for the manufacture of diagnostic means for or for diagnosing prostate carcinomas. Finally, the present invention pertains to a method for identifying prostate carcinoma-related metabolites. | 05-17-2012 |
20130140452 | MEANS AND METHODS FOR DIAGNOSING PANCREATIC CANCER IN A SUBJECT - The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing pancreatic cancer in a subject, a method for identifying whether a subject is in need for a therapy of pancreatic cancer or a method for determining whether a pancreatic cancer therapy is successful. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices. | 06-06-2013 |
20130198911 | Process for the Production of Fine Chemicals - The present invention relates to a process for the production of fine chemicals in a microorganism, a plant cell, a plant, a plant tissue or parts thereof. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antisense molecules, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use. | 08-01-2013 |
20130340119 | Method for Increasing Yield and Fine Chemical Production in Plants - A method for enhancing yield-related traits in plants by modulating expression in a plant of a nucleic acid encoding a POI (Protein Of Interest) polypeptide is provided. Methods for the production of plants having modulated expression of a nucleic acid encoding a DnaJ-like chaperone polypeptide are provided, in which plants have enhanced yield-related traits compared to control plants. Nucleic acids encoding DnaJ-like chaperone, constructs comprising the same and uses thereof are also provided. | 12-19-2013 |
20140030744 | Means and Methods for Diagnosing Gastric Bypass and Conditions Related Thereto - The present invention relates to the field of diagnostic measures. Specifically, it contemplates a method for assessing whether gastric bypass therapy was successful in a subject, a method of predicting whether gastric bypass therapy will be beneficial for a subject in need thereof, and a method of diagnosing whether a supportive therapy accompanying gastric bypass has beneficial effects on a subject in need thereof. Further provided are diagnostic methods for diabetes and body lean mass. Furthermore, the invention relates to a method for identifying a treatment against diabetes and/or obesity. | 01-30-2014 |
20140199313 | Process for the Production of Fine Chemicals - The present invention relates to a process for the production of the fine chemical in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof, preferably in plastids. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use. | 07-17-2014 |
20140259212 | Process for the Production of Fine Chemicals - The present invention relates to a process for the production of a fine chemical in a non-human organism, like a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, expression cassettes, vectors, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use. | 09-11-2014 |
20140323352 | Means and Methods for Diagnosing Pancreatic Cancer in a Subject - The present invention relates to the field of diagnostic methods. Specifically, the present invention contemplates a method for diagnosing pancreatic cancer in a subject, a method for identifying whether a subject is in need for a therapy of pancreatic cancer or a method for determining whether a pancreatic cancer therapy is successful. The invention also relates to tools for carrying out the aforementioned methods, such as diagnostic devices. | 10-30-2014 |
20140325709 | PROCESS FOR THE PRODUCTION OF FINE CHEMICALS - The present invention relates to a process for the production of fine chemicals in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof. The present invention relates further to a process for the control of the production of fine chemicals in a microorganism, a plant cell, a plant, a plant tissue or in one or more parts thereof. The invention furthermore relates to nucleic acid molecules, polypeptides, nucleic acid constructs, vectors, antisense molecules, antibodies, host cells, plant tissue, propagation material, harvested material, plants, microorganisms as well as agricultural compositions and to their use. | 10-30-2014 |
20150241406 | Means and Methods for Diagnosing Recurrence of Prostate Cancer After Prostatectomy - The present invention concerns means and methods for cancer diagnosis and, in particular, diagnosis of prostate cancer. Specifically, it relates to a method for diagnosing whether a subject is at risk for recunent prostate carcinoma after prostatectomy comprising determining the amount of at least one metabolite selected from Table 2 in a test sample of a subject after prostatectomy, and comparing the determined amount to a reference, whereby it is diagnosed whether the subject is at risk for recurrent prostate carcinoma after prostatectomy. Further methods provided in accordance with the present invention relate to differentiating between a malignant prostate carcinoma tissue and a non-malignant tissue and diagnosing metastasizing prostate carcinoma in a subject. Also provided are devices for carrying out the aforementioned methods. | 08-27-2015 |
20150291971 | METHOD FOR PRODUCING A TRANSGENIC CELL WITH INCREASED GAMMA-AMINOBUTYRIC ACID (GABA) CONTENT - This invention relates generally to a method for producing a transgenic cell with increased gamma-aminobutyric acid (GABA) content as compared to a corresponding non-transformed wild type cell. | 10-15-2015 |
20160003799 | Means and Methods for Assessing the Quality of a Biological Sample - The present invention relates to the field of diagnostic methods. Specifically, the present invention relates to a method for assessing the quality of a biological sample comprising the steps of determining in a sample the amount of at least one biomarker from Tables 1, 1′, 2, 2′, 3, 3′, 4, 5, 5′, 6, 7, and/or 8 and comparing the said amount of the at least one biomarker with a reference, whereby the quality of the sample is assessed. The invention also relates to tools for carrying out the aforementioned method, such as devices and kits. | 01-07-2016 |
Beate Kätz, Steinbrunnd AT
Patent application number | Description | Published |
---|---|---|
20100324090 | COMPOSITIONS OF TOLPERISONE - The present disclosure is directed to methods for providing tolperisone having extremely low levels of 4-MMPPO (2-methyl-1-(4-methylphenyl)-propenone), as well as related compositions. The invention further relates to methods of treating a subject with tolperisone under conditions that limit exposure of the subject to tolerable levels of 4-MMPPO, among other features. | 12-23-2010 |
Beate Kätz, Steinbrunnd AT
Patent application number | Description | Published |
---|---|---|
20100324090 | COMPOSITIONS OF TOLPERISONE - The present disclosure is directed to methods for providing tolperisone having extremely low levels of 4-MMPPO (2-methyl-1-(4-methylphenyl)-propenone), as well as related compositions. The invention further relates to methods of treating a subject with tolperisone under conditions that limit exposure of the subject to tolerable levels of 4-MMPPO, among other features. | 12-23-2010 |
Beate Katzschner, Reinhardtsdorf DE
Patent application number | Description | Published |
---|---|---|
20090124488 | Substrate with Spatially Selective Metal Coating, Method for Production and Use Thereof - A substrate with spatially selective metal coating is produced by first applying biological templates onto parts of the surface of the substrate and applying a metal coating only once the biological templates have been deposited on the substrate. The biological templates are for example surface layer proteins (S-layer) and the metal coating is a noble metal coating. The substrates with spatially selective metal coating are used in catalysts or solid-state electrolyte sensors. | 05-14-2009 |
Beate Kehrel, Rheine DE
Patent application number | Description | Published |
---|---|---|
20140044796 | DETECTION AND REMOVAL OF MISFOLDED PROTEINS/PEPTIDES - The invention concerns the field of detecting and quantifying misfolded proteins/peptides. In particular the detection and quantification of misfolded proteins/peptides in body fluids, on cell surfaces of humans and mammals, the detection of misfolded proteins/peptides in reagents to be tested for scientific research and/or diagnostic use and in pharmaceutical medication or their additives and it concerns as well the removal of misfolded proteins/peptides from reagents to be tested for scientific research and/or for diagnostic purposes and from pharmaceutical medication or their additives. Furthermore the invention includes substances to identify and methods to detect bio-films, a method to examine hemocompatibility of materials and a method to optimize therapeutical products, and to provide reagents microorganisms to charge with for more reliable diagnostics and quality control of biopharmaceuticals and identification substances for the screening for preliminary stages of amyloids that can be used for technical purposes. | 02-13-2014 |
Beate Kehrel, Muenster DE
Patent application number | Description | Published |
---|---|---|
20090036360 | MEDICAMENT CONTAINING ACTIVATED ANTITHROMBIN III - The invention concerns the use of antithrombin III with a modified conformation which is referred to as activated antithrombin III (IDAAT=immune defence activated antithrombin) as a medicament. | 02-05-2009 |
20130142779 | Treatment of Hi-Virus infections with oxidised blood proteins - The invention relates to the field of medicaments for combating an infection of a host cell by HI viruses and/or for inhibiting binding of an Env protein to a CD4 protein. For these purposes, the invention provides medicaments which comprise oxidized proteins, oxidized peptides and/or peptidomimetics of such oxidized proteins and/or oxidized peptides, as well as preparation processes for such medicaments and therapeutic and non-therapeutic possible uses of these medicaments. | 06-06-2013 |
Beate Kinga Jaszczuk, Munster DE
Patent application number | Description | Published |
---|---|---|
20110087012 | NUCLEIC ACID MOLECULES CODING FOR A PROTEIN WITH DEACETYLASE ACTIVITY, SAID PROTEIN, AND METHOD FOR THE PRODUCTION OF CHITOSAN - The invention relates to nucleic acid molecules selected from the group comprising: a) nucleic acid molecules that code for a form of the polypeptide with the derived amino acid sequence according to SEQ ID No. 3, said polypeptide having a deacetylase activity; b) nucleic acid molecules that comprise the nucleotide sequence according to SEQ ID No. 1 or SEQ ID No. 2 and that code for one form of said polypeptide; c) nucleic acid molecules that code for a fragment or a derivative of a polypeptide that is coded by a nucleic acid molecule according to a) or b), wherein one or more amino acid groups are conservatively substituted in said derivative as compared to said polypeptide, and wherein said fragment or derivative has a deacetylase activity; d) nucleic acid molecules that have a sequence identity of at least 95% with a nucleic acid molecule according to a) to c), and that code for a polypeptide with deacetylase activity; e) nucleic acid molecules that have a sequence identity of at least 70% with a nucleic acid molecule according to a) to c) and that code for a polypeptide with deacetylase activity; f) or the complementary string of a nucleic acid molecule according to a) to e). | 04-14-2011 |
Beate Koksch, Berlin DE
Patent application number | Description | Published |
---|---|---|
20120016103 | PEPSTATIN A DERIVATIVES - The invention relates to a compound having a structure according to the general formula P3-P2-P1-P1′-P2′ (I), wherein residues P3, P2, P1, P1′ and P2′ are specifically defined and may be, e.g., certain amino acid residues. The invention further relates to the use of said compound and to a method for synthesizing a peptide. | 01-19-2012 |
Beate Koschorreck, Schriesheim DE
Patent application number | Description | Published |
---|---|---|
20100172798 | METHOD FOR THE PRODUCTION OF AN ANALYTICAL ELEMENT - A method is provided for producing an analytical element comprising at least one test field for analyzing a liquid sample, wherein provision is made for a carrier on which a polymer fabric is arranged. At least one portion of the polymer fabric is irradiated with UV laser light and thereby hydrophobized. | 07-08-2010 |
20120045825 | DIAGNOSTIC TEST TAPE FOR LIQUID SAMPLES - A diagnostic test tape for liquid samples is provided comprising a flexible transport tape and a plurality of test fields applied to the transport tape that are distributed in the longitudinal direction of the tape, where said test fields comprise a detection layer and a spreading net spanning the detection layer for a planar uptake of liquid sample, wherein the spreading net is formed from a lattice-like fabric comprising fabric threads that cross at right angles. In order to prevent the fabric from arching up under tape tension it is proposed that the fabric is oriented obliquely to the transport tape such that all fabric threads run obliquely to the longitudinal direction of the tape. | 02-23-2012 |
Beate Langenhan, Niederkrüchten DE
Patent application number | Description | Published |
---|---|---|
20080317589 | Compressor Housing for Use at Low Temperatures - The invention relates to a turbo machine comprising a housing. Said turbo machine is designed especially as a turbo compressor for use at low temperatures, the housing preferably being made of a cold-resistant material that has a martensitic structure. | 12-25-2008 |
20090242084 | Method for Producing a Shaft for Compressors - A method for the production of steels is provided. A heat treatment is carried out, in which the steel is hardened in water twice at different high temperatures, and subsequently subjected to an annealing treatment. It has been shown that the steel 26NiCrMoV14-5 has a high subzero toughness. In one aspect, the steel is usable down to a temperature of at least minus 170° C. | 10-01-2009 |
Beate Langenhan, Niederkrüchten DE
Patent application number | Description | Published |
---|---|---|
20090242084 | Method for Producing a Shaft for Compressors - A method for the production of steels is provided. A heat treatment is carried out, in which the steel is hardened in water twice at different high temperatures, and subsequently subjected to an annealing treatment. It has been shown that the steel 26NiCrMoV14-5 has a high subzero toughness. In one aspect, the steel is usable down to a temperature of at least minus 170° C. | 10-01-2009 |
Beate Maassen-Francke, Oelde DE
Patent application number | Description | Published |
---|---|---|
20090013934 | AUTOMATIC SEPARATION OF ANIMAL MILK - The invention relates to, inter alia, a method for determining a modified waiting period for a milk-producing animal treated with a veterinary medicament. According to said method, at least one quantity of milk is determined during at least one time interval following the administration of the veterinary medicament, said interval being shorter than a pre-determined waiting period. A milk yield for the waiting period is predicted from the quantity of milk. A modified waiting period is determined on the basis of the predicted milk yield and a milk yield for the waiting period pre-determined by the veterinary medicament. The inventive method enables MRL values to be surely and reliably maintained, such that milk is separated according to the modified waiting period. | 01-15-2009 |
Beate Meschonat, Hannover DE
Patent application number | Description | Published |
---|---|---|
20160023128 | NON-FLAMMABLE COMPOSITIONS AND USE OF THESE COMPOSITIONS - The invention relates to certain non-flammable compositions containing 1,1,1,3,3-pentafluorobutane (R365mfc), 1,2-dichloroethylene and a hydrofluoroether, to mixtures containing these compositions and to the use of these non-flammable compositions or these mixtures, especially as precision cleaning agents for solid surfaces and for flushing, especially of refrigeration systems. | 01-28-2016 |
Beate Mitschunas, Ilmenau DE
Patent application number | Description | Published |
---|---|---|
20150309332 | Vision Aid for Manipulating the Retinal Image for Eyes Having Macular Degeneration - A compact, efficient and more patient-friendly device for manipulating, in particular enlarging and/or redirecting and/or distorting or altering, image information passing through an optical system is to be provided with this invention. | 10-29-2015 |
Beate Muller, Hanner DE
Patent application number | Description | Published |
---|---|---|
20080287501 | THERAPEUTIC USES OF AN INSULIN SECRETION ENHANCER - The invention relates to the use of a hypolipidemic agent or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the prevention or delay of the progression to overt diabetes, especially type 2, prevention or reduction of microvascular complications (eg, retinopathy, neurophathy, nephropathy), prevention or reduction of excessive cardiovascular morbidity (eg, myocardial infarction, arterial occlusive disease, atherosclerosis and stroke) and cardiovascular mortality, prevention of cancer and reduction of cancer deaths. Additionally, the invention relates to the use of a treatment for diseases and conditions that are associated with IGM, IGT or IFG. | 11-20-2008 |
Beate Neumann, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20140349931 | DETECTION AND TREATMENT OF BREAST CANCER - The present invention describes methods for determining the risk that a breast precursor lesion will progress to invasive breast cancer and/or the risk of recurrent non-invasive disease in a patient, comprising detecting the presence and/or level of PAPPA and/or PAPPA functional activity in a breast tissue sample obtained from the patient, wherein if PAPPA is not present, or is present at a reduced amount compared to a control, there is the risk of progression to invasive cancer and/or the risk or recurrent disease. | 11-27-2014 |
Beate Nothhelfer-Kolb, Untrhaching DE
Patent application number | Description | Published |
---|---|---|
20090235225 | Rule based instantiation of software- and system development processes - A method, system and a computer readable medium for performing a rule based instantiation of a generic software and/or system development process to provide a project specific implemented instantiated process. The proposed approach provides a gradual way to provide an implemented instantiated process adapted to project specific needs by using a staggered instantiation mode. The approach distinguishes between high level instantiation and detailed instantiation depending on the nature of the instantiation operation. The approach is flexibly applicable to software and systems development processes and the set of instantiation operations is extendable. | 09-17-2009 |
Beate Pscheidt, Hart-Purgstall AT
Patent application number | Description | Published |
---|---|---|
20100143986 | R-HNL RANDOM VARIANTS AND THEIR USE FOR PREPARING OPTICALLY PURE, STERICALLY HINDERED CYANOHYDRINS - The invention relates to R-hydroxynitrile lyases with improved substrate acceptance, increased activity and increased selectivity, obtainable by introducing random mutations with the aid of random mutagenesis and/or saturation mutagenesis techniques, identifying by means of screening or selection and, where appropriate, subsequently combining advantageous mutations, and to the use thereof. | 06-10-2010 |
Beate Riefer, Walldorf DE
Patent application number | Description | Published |
---|---|---|
20140122144 | Initiative and Project Management - An initiative object corresponding to an organization decision to explore a topic is defined, and a first goal definition and a first skills definition for the initiative object are defined. A project object corresponding to a project undertaken by the organization is defined, the project associated with exploring the topic, and a second goal definition and a second skills definition for the project object are defined. Employees are searched in an employee skills database using at least one of the first or second skills definitions, and assigned to the initiative object and to the project object, wherein the project object, but not the initiative object, affects employee availability. Upon closing the initiative object or project object, a skills record is updated using the first or second skills definitions; and upon closing the initiative object or project object, a performance record is updated using the first or second goal definitions. | 05-01-2014 |
Beate Schmidt, Konstanz DE
Patent application number | Description | Published |
---|---|---|
20140073672 | NOVEL PYRAZOLONE-DERIVATIVES AND THEIR USE AS PDE-4 INHIBITORS - The compounds of Formula (I), | 03-13-2014 |
Beate Schmitz, Köln DE
Patent application number | Description | Published |
---|---|---|
20150376168 | SALT POLYMORPH OF THIOXANTHENE-9-YLIDENE-1-METHYL PIPERIDINE ACID ADDITION SALTS AS ANTIMIGRAINE COMPOUNDS - The present invention relates to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine salts and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine salts; especially to novel crystal forms of 4-(6-ethoxy-1-methoxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride and 4-(6-ethoxy-1-hydroxy-thioxanthene-9-ylidene)-1-methyl piperidine hydrochloride as well as to the use of these salts for preventing or treating migraine or pulmonary hypertension. | 12-31-2015 |
Beate Sczekalla, Halle DE
Patent application number | Description | Published |
---|---|---|
20110076502 | PURIFIED ACETYLATED DERIVATIVES OF CASTOR OIL AND COMPOSTIONS INCLUDING SAME - The present disclosure is directed to a single phase acetylated castor component (SP-ACC). An acetylated castor component is purified to produce the SP-ACC which contains a reduced amount of, or no, insoluble component(s) therein. The SP-ACC enhances the performance and properties of plasticizers of which it is a component. | 03-31-2011 |
20120181057 | Acetylate Glycerin Esters and Their Blends with Epoxidized Fatty Acid Esters - The present disclosure is direct to acetylated glycerin ester and compositions including the same. The acetylated glycerin ester may be blended with other plasticizers, including an epoxidized fatty acid ester. The present acetylated glycerin ester and blends find advantageous application as a plasticizer. | 07-19-2012 |
20120181061 | Acetylated Derivatives of Castor Oil and Their Blends with Epoxidized Fatty Acid Esters - The present disclosure is directed to acetylated castor components and compositions including the same. The acetylated castor component may be an acetylated castor oil and/or an acetylated castor wax. The acetylated castor component may be blended with an epoxidized fatty acid ester. The present acetylated castor components and blends find advantageous application as a plasticizer. | 07-19-2012 |
20140000933 | Purified Acetylated Derivatives of Castor Oil and Compositions Including Same | 01-02-2014 |
20140323622 | Acetylated Derivatives of Castor Oil and Their Blends with Epoxidized Fatty Acid Esters - The present disclosure is directed to acetylated castor components and compositions including the same. The acetylated castor component may be an acetylated castor oil and/or an acetylated castor wax. The acetylated castor component may be blended with an epoxidized fatty acid ester. The present acetylated castor components and blends find advantageous application as a plasticizer. | 10-30-2014 |
Beate Sczekalla, Kabelsketal-Zwintschoena DE
Patent application number | Description | Published |
---|---|---|
20150129279 | ACETYLATED POLYOL HYDROXYSTEARATE PLASTICIZERS AND PLASTICIZED POLYMERIC COMPOSITIONS - Plasticizers comprising an acetylated polyol hydroxystearate and plasticized polymeric compositions comprising such plasticizers. Such plasticized polymeric compositions can be employed in forming various articles of manufacture, such as coated conductors. | 05-14-2015 |
Beate Sczekalla, Kabelsketal DE
Patent application number | Description | Published |
---|---|---|
20120181056 | Acetylated Polyglycerine Fatty Acid Ester and a PVC Insulator Plasticised Therewith - The present disclosure is directed to acetylated polyglyceride fatty acid ester and compositions containing the same. The acetylated polyglyceride fatty acid ester may be blended with an epoxidized fatty acid ester. The present acetylated polyglyceride fatty acid ester and blends find advantageous application as a plasticizer. | 07-19-2012 |
Beate Simon, Eschborn DE
Patent application number | Description | Published |
---|---|---|
20150065973 | Absorbent Articles With Channels - The present disclosure is directed, in part, to an absorbent article comprising a liquid management system (LMS) and an absorbent core disposed at least partially intermediate a topsheet and a backsheet. The LMS defines one or more channels therein. The one or more channels of the LMS may at least partially overlap or not overlap with channels defined in the absorbent core. | 03-05-2015 |
20150065975 | Absorbent Articles With Channels - The present disclosure is directed, in part, to an absorbent article comprising a liquid management system (LMS) and an absorbent core disposed at least partially intermediate a topsheet and a backsheet. The LMS defines one or more channels therein. The one or more channels of the LMS may at least partially overlap or not overlap with channels defined in the absorbent core. | 03-05-2015 |
20150065976 | ABSORBENT ARTICLES WITH CHANNELS - The present disclosure is directed, in part, to an absorbent article that comprises a liquid management system (LMS) and an absorbent core disposed at least partially intermediate a topsheet and a backsheet. The LMS defines one or more channels substantially free of superabsorbent polymers. The one or more channels of the LMS may at least partially overlap channels defined by the absorbent core. The absorbent article may comprises a liquid distribution system (LDS) that defines one or more channels. | 03-05-2015 |
Beate Stern, Beate NO
Patent application number | Description | Published |
---|---|---|
20110136236 | GENETICALLY MODIFIED EUKARYOTIC CELLS - The invention relates to a method of producing genetically modified eukaryotic cells with optimised growth characteristics wherein a recombinant first nucleotide sequence has been integrated into a desired position in the genome. The sequence contains at least one gene encoding a plasma membrane protein with either toxin-receptor or toxic properties and allowing for surface expression based cell sorting to identify a suitable genomic integration locus. The invention also relates to a second exogenous nucleotide sequence containing at least one protein of interest as well as a vector, which aids in the site specific exchange of the first with the second nucleotide sequence. Efficient exchange is achieved by a stringent selection strategy that will kill all cells still expressing the plasma membrane protein. | 06-09-2011 |
Beate Strehlitz, Leipzig DE
Patent application number | Description | Published |
---|---|---|
20140141446 | Aptamers That Are Specific for Immunoglobulin-Binding Cell Wall Proteins - The invention relates to an aptamer that binds to protein A, G or L, protein A-, G- or L-containing substances, and also to protein A-, G- or L-containing microorganisms, in particular | 05-22-2014 |
20140303030 | METHOD FOR IDENTIFYING APTAMERS - The invention relates to a method for identifying aptamers, having the following steps bringing a mixture of oligonucleotides into contact with an aptamer target structure and binding at least some of the oligonucleotides to the target structure, separating the oligonucleotides which have been bound to the aptamer target structure from the aptamer target structure and from oligonucleotides that are not bound to the aptamer target structure, amplifying individual oligonucleotides which were bound to the aptamer target structure in a physically separate manner and producing a plurality of physically separate amplicons, each amplicon predominantly containing one type of oligonucleotides, specifying a specific marker for a plurality of the physically separate amplicons such that each of the marked amplicons can be uniquely identified using the specified marker of the amplicon, sequencing oligonucleotides in a plurality of marked amplicons and assigning the marker that is specific for the amplicon to the sequence of the type of oligonucleotides in the amplicon for each amplicon examined by means of the sequencing process analyzing the binding properties of the types of oligonucleotides to the aptamer target structure and assigning the analyzed binding properties to the specific markers of the amplicons and to the sequences of the types of oligonucleotides. | 10-09-2014 |
Beate Treffler, Neusaess DE
Patent application number | Description | Published |
---|---|---|
20110275837 | Waxes Having High Polarity and the Use Thereof as Slip Agents for Chlorine-Containing Thermoplastics - Copolymer waxes, characterized by an iodine number of <15, preferably <13 g of iodine/100 g, a viscosity at 100° C. ranging between 200 to 4000 mPa*s, a dropping point ranging between 60 to 90° C., a ram penetration hardness ranging between 200 to 600 bar, an acid number ranging between 60 to 100 mg of KOH/g, and an iodine color number<10. The copolymer waxes according to the invention are suited in particular as processing aids for PVC, polyvinylidene chloride and copolymers of vinyl chloride, having up to 30% by weight comonomers. | 11-10-2011 |
Beate Treffler, Neusäß DE
Patent application number | Description | Published |
---|---|---|
20140364551 | USE OF WAXLIKE PRODUCTS FOR PLASTICS PROCESSING - The instant invention relates to the use of waxlike esters as lubricants for halogen containing thermoplastics. The waxlike esters are prepared by A) metathetic oligomerization of esters of polyols and fatty acids, and B) subsequent hydrogenation of the resultant reaction mixture, at least some of the fatty acid units present in the polyol esters being singly or multiply unsaturated. | 12-11-2014 |
Beate Von Teichmann, Annlin ZA
Patent application number | Description | Published |
---|---|---|
20110091500 | Inactivated Live-Attenuated Bluetongue Virus Vaccine - The invention describes the preparation of an inactivated bluetongue virus (BTV) composition, and in particular a vaccine, using an attenuated live BTV vaccine strain as masterseed. The vaccine can be administered to an animal to prevent bluetongue disease by eliciting an immune response against the bluetongue virus serotype(s) included in the composition. | 04-21-2011 |
Beate Walter, Stutensee DE
Patent application number | Description | Published |
---|---|---|
20100070016 | STENT DEVICE ADHESIVELY BONDED TO A STENT DEVICE PUSHER - A stent device delivery system, comprising a stent device pusher, a radially expandable stent device and an outer sheath. A tacky material provides a tackiness between the stent device pusher and an inner surface of the stent device. The tacky material is distributed along the length of the stent device. The tacky material serves to resist axial movement of the stent device relative to the stent device pusher as the outer sheath slides axially over the stent device, yet allows the stent device to peel from the tacky material and expand to a radially expanded state as the outer sheath slides axially over the stent device to release the stent device. The tacky material may be compressible such that the stent device is embedded in the compressible tacky material. | 03-18-2010 |
20100179637 | TRANS-LUMINAL SURGICAL DEVICE - A device for trans-luminal delivery of a self-expanding stent or other surgical device and which is designed for rapid exchange over a guidewire has a guidewire lumen that adjacent its proximal exit port lies side-by-side with the line of the shaft of the device. A sleeve which surrounds and confines the stent has a proximal end that is shaped around the guidewire exit port to show in profile a shape reminiscent of the nose of a dolphin. In preferred embodiments, the sleeve also has a tapered distal tip that is withdrawn proximally over the length of the stent to release it, progressively, from its distal end. The configuration delivers simplicity of design, enhanced performance and reliability in use. | 07-15-2010 |
20120059449 | DELIVERY DEVICE FOR DELIVERING A STENT DEVICE - A delivery device ( | 03-08-2012 |
20120143304 | TRANSLUMINAL DELIVERY SYSTEM - There is disclosed herein a transluminal delivery system for a self-expanding luminal prosthesis, the system comprising an inner catheter component ( | 06-07-2012 |
20150088242 | Transluminal Delivery System - A transluminal delivery system and a method of assembling. The system includes a cylindrical, inner-catheter component and a retractable sheath surrounding the component and defining a space between the component and the sheath to receive a self-expanding luminal prosthesis between the component and the sheath. The inner-catheter component may include at least one sleeve having fibers, at least one connected sleeve portion connected to the inner catheter, and at least one unconnected sleeve portion slidably engaging the inner catheter such that when the sheath retracts, the unconnected portion expands and sleeve fibers engage the prosthesis's luminal surface, wherein the engagement opposes proximal stent movement. | 03-26-2015 |
20150313733 | Method of Transferring a Stent Device from a Crimping Head to an Outer Sheath of a Stent Device Delivery System - A method of moving a stent device into an outer sheath of a stent device delivery system is disclosed. The stent device ( | 11-05-2015 |
Beate Ziak-Beyerlein, Numberg DE
Patent application number | Description | Published |
---|---|---|
20100203286 | Structured component, in particular a shielding element in the form of a heat shield - The invention relates to a structured component, in particular a shielding element in the form of a heat shield, comprising a shielding body ( | 08-12-2010 |
Beate Zietek-Strietz, Heidelberg DE
Patent application number | Description | Published |
---|---|---|
20100034650 | CENTRIFUGAL PUMP - The invention relates to a centrifugal pump, in particular, a single stage or multi-stage side channel pump in a modular design, wherein the stage or every stage of the pump comprises a preferably divided modular housing with assigned centrifugal impellers, which are designed so as to be self-supporting; and, thus, a pump shaft, which is known in the prior art, is no longer necessary. | 02-11-2010 |
Beate Zika-Beyerlein, Nurnberg DE
Patent application number | Description | Published |
---|---|---|
20080292832 | Structural component in the form of a heat shield - The invention relates to a structural component in the form of a heat shield, consisting of at least two interconnected structural layers, of which one structural layer ( | 11-27-2008 |
20120055527 | STRUCTURAL ELEMENT FOR THERMALLY SHIELDING ENGINES OR ENGINE COMPONENTS, IN PARTICULAR A HEAT SHIELD FOR COMBUSTION ENGINES - The invention relates to a structural element for thermally shielding engines or engine components, in particular a heat shield for combustion engines, the structural element having a planar extension and comprising a first side that faces a hot element of the engine, and a second side that faces away from the hot element of the engine, characterized in that the structural element comprises a thermoelectric generator, which can be used to generate electric energy from a temperature difference resulting between the first side and the second side of the structural element during operation of the engine. | 03-08-2012 |